Publicacións nas que colabora con MARÍA LUZ LÓPEZ RODRÍGUEZ (5)

2007

  1. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions

    Life Sciences, Vol. 80, Núm. 10, pp. 979-988

2006

  1. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

    European Neuropsychopharmacology, Vol. 16, Núm. 1, pp. 7-18

2003

  1. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

    European Journal of Medicinal Chemistry

  2. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase

    Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 1512-1522

2002

  1. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

    European Journal of Pharmacology, Vol. 449, Núm. 1-2, pp. 99-103